Literature DB >> 11716152

Endocrine sequelae of cancer therapy in childhood.

F B Diamond1, B B Bercu.   

Abstract

New treatments for neoplastic diseases of childhood have significantly increased patients' long-term survival and the importance of recognizing and correcting late complications of medical therapy. In this review, we examine both central nervous system (CNS) and non-CNS-related endocrine morbidities associated with chemotherapy and radiation therapy of childhood cancer. These include effects on growth, puberty, fertility, thyroid and adrenal function which may present many years after the successful treatment of underlying disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716152     DOI: 10.1007/bf03343910

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  65 in total

1.  Effects of radiation on ovarian function in long-term survivors of childhood acute lymphoblastic leukemia: a report from the Childrens Cancer Study Group.

Authors:  M R Hamre; L L Robison; M E Nesbit; H N Sather; A T Meadows; J A Ortega; G J D'Angio; G D Hammond
Journal:  J Clin Oncol       Date:  1987-11       Impact factor: 44.544

Review 2.  Evaluation of pituitary function in children using growth hormone secretagogues.

Authors:  B B Bercu; R F Walker
Journal:  J Pediatr Endocrinol Metab       Date:  1996-06       Impact factor: 1.634

3.  Pooled prolactin measurements in the evaluation of short children.

Authors:  D I Shulman; C S Hu; A W Root; B B Bercu
Journal:  J Clin Endocrinol Metab       Date:  1989-12       Impact factor: 5.958

4.  Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia.

Authors:  A D Leiper; R Stanhope; P Kitching; J M Chessells
Journal:  Arch Dis Child       Date:  1987-11       Impact factor: 3.791

5.  Growth response to growth hormone therapy following craniospinal irradiation.

Authors:  P E Clayton; S M Shalet; D A Price
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

6.  Endocrine function following single fraction and fractionated total body irradiation for bone marrow transplantation in childhood.

Authors:  B C Thomas; R Stanhope; P N Plowman; A D Leiper
Journal:  Acta Endocrinol (Copenh)       Date:  1993-06

7.  Thyroid dysfunction after radiotherapy in children with Hodgkin's disease.

Authors:  L S Constine; S S Donaldson; I R McDougall; R S Cox; M P Link; H S Kaplan
Journal:  Cancer       Date:  1984-02-15       Impact factor: 6.860

8.  Therapeutic radiation at a young age is linked to secondary thyroid cancer. The Late Effects Study Group.

Authors:  M A Tucker; P H Jones; J D Boice; L L Robison; B J Stone; M Stovall; R D Jenkin; J H Lubin; E S Baum; S E Siegel
Journal:  Cancer Res       Date:  1991-06-01       Impact factor: 12.701

9.  Growth in children treated for acute lymphoblastic leukaemia.

Authors:  P E Clayton; S M Shalet; P H Morris-Jones; D A Price
Journal:  Lancet       Date:  1988-02-27       Impact factor: 79.321

10.  Thyroid nodular disease after radiotherapy to the neck for childhood Hodgkin's disease.

Authors:  E A Shafford; J E Kingston; J C Healy; J A Webb; P N Plowman; R H Reznek
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

View more
  3 in total

Review 1.  Adverse effects of treatment in childhood acute lymphoblastic leukemia: general overview and implications for long-term cardiac health.

Authors:  Kirsten K Ness; Saro H Armenian; Nina Kadan-Lottick; James G Gurney
Journal:  Expert Rev Hematol       Date:  2011-04       Impact factor: 2.929

2.  Gonadal function in patients treated for Hodgkin's disease in childhood.

Authors:  Lorna Zadravec Zaletel; Nevenka Bratanic; Berta Jereb
Journal:  Radiol Oncol       Date:  2010-09-09       Impact factor: 2.991

3.  Canadian Study of Determinants of Endometabolic Health in ChIlDrEn (CanDECIDE study): a cohort study protocol examining the mechanisms of obesity in survivors of childhood brain tumours.

Authors:  M Constantine Samaan; Lehana Thabane; Sarah Burrow; Rejane F Dillenburg; Katrin Scheinemann
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.